As of April 1st, 2022, the US FDA Office of Tissues and Advanced Therapies (OTAT) has approved 23 cell and gene therapy products. (US FDA OTAT)
The Arrival of
in the Epoch of Precision Medicine
Our team is passionate about clearly communicating the most innovative areas of the life sciences. To help prepare the industry for this new therapeutic age, check out some key highlights in this infographic.
WHAT ARE CELL & GENE THERAPIES?

GENE THERAPY

CELL THERAPY
AN INSIDE LOOK AT CELL AND GENE THERAPY STRATEGIES
GENE THERAPIES

CELL THERAPIES

REAL WORLD APPLICATIONS
That day back in 2010 when I was infused with my CAR-Ts, and my tumor cells disappeared – it meant there was a whole new treatment paradigm.
THE DISCOVERY & DEVELOPMENT PATHWAY





LOOKING AHEAD AT WHAT'S NEXT FOR CELL & GENE THERAPY
By the middle of 2021, there were nearly 1,200 organizations developing gene, cell, and tissue-based therapeutics worldwide, with over 2,600 trials ongoing, including a few hundred in Phase 3 (ARM 2021 H1 Report)
Recent research estimates that about 350,000 patients will have received a cell or gene therapy by 2030, with between 30 to 60 products approved available. (Quinn, et al. Value Health 2019)
The cell and gene therapy market is expected to grow tremendously in the coming decade. Market research groups expect impressive growth—estimated between 24.1% and 33.82% annually—with the cell and gene therapy market potentially reaching up to $25 Billion in 2027 from $2.6 Billion in 2020. (Cell and Gene Therapy Global Market Report &Global Cell and Gene Therapy Market.)
As of April 1st, 2022, the US FDA Office of Tissues and Advanced Therapies (OTAT) has approved 23 cell and gene therapy products. (US FDA OTAT)
By the middle of 2021, there were nearly 1,200 organizations developing gene, cell, and tissue-based therapeutics worldwide, with over 2,600 trials ongoing, including a few hundred in Phase 3 (ARM 2021 H1 Report)
Recent research estimates that about 350,000 patients will have received a cell or gene therapy by 2030, with between 30 to 60 products approved available. (Quinn, et al. Value Health 2019)
The cell and gene therapy market is expected to grow tremendously in the coming decade. Market research groups expect impressive growth—estimated between 24.1% and 33.82% annually—with the cell and gene therapy market potentially reaching up to $25 Billion in 2027 from $2.6 Billion in 2020. (Cell and Gene Therapy Global Market Report &Global Cell and Gene Therapy Market.)